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Abstract
Background: Cognitive Behaviour Therapy (CBT) is the front-line psychological intervention for step 3 within UK
psychological therapy services. Counselling is recommended only when other interventions have failed and its
effectiveness has been questioned.
Method: A secondary data analysis was conducted of data collected from 33,243 patients across 103 Improving
Access to Psychological Therapies (IAPT) services as part of the second round of the National Audit of Psychological
Therapies (NAPT). Initial analysis considered levels of pre-post therapy effect sizes (ESs) and reliable improvement
(RI) and reliable and clinically significant improvement (RCSI). Multilevel modelling was used to model predictors of
outcome, namely patient pre-post change on PHQ-9 scores at last therapy session.
Results: Counselling received more referrals from patients experiencing moderate to severe depression than CBT.
For patients scoring above the clinical cut-off on the PHQ-9 at intake, the pre-post ES (95% CI) for CBT was 1.59 (1.
58, 1.62) with 46.6% making RCSI criteria and for counselling the pre-post ES was 1.55 (1.52, 1.59) with 44.3% of
patients meeting RCSI criteria. Multilevel modelling revealed a significant site effect of 1.8%, while therapy type was
not a predictor of outcome. A significant interaction was found between the number of sessions attended and
therapy type, with patients attending fewer sessions on average for counselling [M = 7.5 (5.54) sessions and a
median (IQR) of 6 (3–10)] than CBT [M = 8.9 (6.34) sessions and a median (IQR) of 7 (4–12)]. Only where patients
had 18 or 20 sessions was CBT significantly more effective than counselling, with recovery rates (95% CIs) of 62.2%
(57.1, 66.9) and 62.4% (56.5, 68.0) respectively, compared with 44.4% (32.7, 56.6) and 42.6% (30.0, 55.9) for
counselling. Counselling was significantly more effective at two sessions with a recovery rate of 34.9% (31.9, 37.9)
compared with 22.2% (20.5, 24.0) for CBT.
Conclusions: Outcomes for counselling and CBT in the treatment of depression were comparable. Research efforts
should focus on factors other than therapy type that may influence outcomes, namely the inherent variability
between services, and adopt multilevel modelling as the given analytic approach in order to capture the naturally
nested nature of the implementation and delivery of psychological therapies. It is of concern that half of all
patients, regardless of type of intervention, did not show reliable improvement.
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Background
In England, the publication of the Depression Report [1]
set in motion a sea change in the policy and implemen-
tation of psychological services in the country. The
report argued that there were effective psychological in-
terventions available, essentially Cognitive Behaviour
Therapy (CBT), but that services were not implementing
evidence-based therapies according to National Institute
for Health and Care Excellence (NICE) guidance. In
order to respond to the high rates of depression and
anxiety and combined with an economic argument that
the savings on benefits would balance the costs of the
programme, the UK government invested an initial £33
million into the Improving Access to Psychological
Therapies (IAPT) programme. It was then rolled out in
2008 with the aim of providing evidence-based psycho-
logical therapies to adults in England experiencing
anxiety disorders and depression [1]. Further invest-
ments of £110 million and £173 million were provided
in 2009/10 and 2010/11 [2].
In line with the NICE Guidelines for Depression in
adults [3], IAPT adopted a stepped care model where pa-
tients are assessed (step 2) by Psychological Wellbeing
Practitioners (PWPs) with the expectation that they will
treat the majority of patients. Only those patients who
are severe on referral or who show no improvement
within a period of time from a step two intervention are
‘stepped up’ to a high-intensity intervention (step 3) [4].
Within the same guidelines, NICE recommended CBT
as the frontline psychological therapy. By contrast, coun-
selling was viewed as a second line intervention where
counsellors were required to ‘Discuss with the person
[patient] the uncertainty of the effectiveness of counsel-
ling….in the treatment of depression’ (p.16).
Despite this statement, various studies have examined
the effectiveness of counselling, often referred to as non-
directive supportive therapy (NDST), as a treatment for
adult depression [4, 5]. In all of these studies non-
directive supportive therapy is an unstructured therapy
where the therapist refrains from giving advice or mak-
ing interpretations and the therapy typically is not aimed
at providing solutions or acquiring new skills [6, 7].
In terms of evidence from meta-analytic studies, one
meta-analysis marshalled data from 34 randomized
controlled trials of brief psychological therapies of adult
patients with anxiety, depression or mixed common
mental health problems treated in primary care com-
pared to primary care treatment as usual [8]. The
authors reported brief CBT, counselling, and problem
solving therapy all to be effective treatments in primary
care, but effect sizes were lower compared to longer
length treatments [8]. In another meta-analysis, 67 studies
were analysed [9]. Results suggested that treatment with
non-directive supportive counselling was less efficacious
than pharmacotherapy. In an earlier meta-analysis of 31
studies, Cuijpers and colleagues found non-directive
counselling to be effective in the treatment of depression
in adults but that it was somewhat less effective than other
more structured psychological treatments [7]. However,
all the effect size differences were small, and in one study
were no longer present after controlling for researcher
allegiance [6]. Additionally, as highlighted by Cuijpers and
colleagues, the types of therapies grouped together as
‘non-directive supportive therapy’ range from client
centred therapy to support groups and there may be great
variability in what is being provided [7].
In terms of evidence from randomised controlled trials
(RCTs), a comparison between non-directive counselling
and cognitive behaviour therapy for mixed anxiety and
depression and also for depression alone reported no
significant difference in outcomes for the two therapies
[10]. A subsequent reanalysis of the subsample meeting
a diagnosis of depression only found similar results with
both therapies being superior to usual General Practice
care at 4 months but not at 12 months [11]. More re-
cently, a trial exploring the effectiveness of acupuncture
and counselling in primary care reported statistically
significant benefits at 3 months associated with both
interventions when provided alongside usual care [12].
The literature would therefore suggest that counselling
is effective and that where differences with CBT occur
they are small (i.e., an effect size <.2). Accordingly, there
appears little supporting evidence for continuing to state
that generic counselling should be regarded as a second-
line treatment for the treatment of depression. However,
concerns about the lack of a single standardized form of
counselling led to initiatives to devise a form of counsel-
ling that was based on a combination of generic and
specific competences within humanistic therapies as well
as drawing on evidence from randomised controlled
trials. This concern led to the development of a blended
form of person-centred experiential therapy termed
Counselling for Depression (CfD) that combined
person-centred counselling with key aspects of emotion
focused therapy drawing on experiential models [13].
Training in CfD has been delivered since 2011 and the
number of funded CfD training places has increased an-
nually [14]. A recent IAPT report showed CBT and
Counselling for Depression (CfD) to be the most widely
accessed interventions with 57% of patients accessing
CBT and 23% accessing CfD [15]. The first published
outcomes following the rollout of CfD training presented
‘recovery rates’ by therapy type and problem descriptor
[15]. Outcome recovery rates were comparable for CBT
(45.9% for depression, 49% for anxiety) and CfD (47.6%
for depression, 46.7% for anxiety). Interestingly, the
average number of sessions attended for CBT (N = 7.1)
was greater than for CfD (N = 5.9).
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However, much of the IAPT counselling provision is
still delivered by qualified counsellors who are not yet
trained in CfD. As reported in the 2015 Adult IAPT
Workforce Census Report, whilst CBT provided 61.9%
of the workforce, CfD accounted for only 5.7% whereas
generic counselling still comprised 11.1% of the IAPT
workforce [16]. Moreover, data collected as part of the
second independent National Audit of Psychological
Therapies [17] indicated generic counselling to be the
second most widely available psychological therapy in
IAPT, with 29.2% of patients receiving counselling com-
pared to 69.3% receiving CBT. The other approved inter-
ventions accounted for less than 2% of the total
provision [18]. In light of the continued practice of
generic counselling, it would be important to determine
its comparative effectiveness as practised immediately
prior to the roll out of CfD within the IAPT service
particularly as, to date, there is no evidence-base derived
from trials attesting to the efficacy of CfD itself or
whether it has yielded improved outcomes or a more
robust evidence-base.
Pre-dating the national rollout of CfD training, evalua-
tions of the initial years of the IAPT programme
provided preliminary data on the comparative outcomes
of the therapies provided by IAPT [19, 20]. An initial
evaluation of the first wave of the IAPT programme
(2008/2009) aimed to determine how successfully the
commitments to accessibility, provision of NICE-
recommended psychological therapies, and outcome
monitoring were progressing. Outcomes were compar-
able for both CBT and generic counselling with approxi-
mately 40% of people moving to recovery (i.e., below
caseness at discharge) in each intervention [19]. A
secondary analysis using a dataset taken from 32 of the
initial roll out IAPT sites used logistic multiple regres-
sion to investigate the variability in performance of these
two therapies and how the variability between sites and
patients affected patients’ recovery. Recovery rates were
found to be comparable to those reported in the initial
evaluation, with approximately 40% of patients moving
to recovery for both interventions [20]. However, only a
relatively small number of sites (N = 18 and 32 respect-
ively) were included in these analyses of IAPT data and
neither accounted for differences between patients or
differences between sites.
The use of rates of reliable and clinically significant
improvement and reliable improvement only are the
current primary methods for reporting outcomes in
IAPT [21, 22]. Each of these two procedures is appropri-
ate for specific situations: reliable and clinically signifi-
cant improvement focuses on only patients who meet
clinical threshold at intake, while reliable improvement
does not require this criterion and can therefore be ap-
plied to virtually all patients referred to a clinical service.
However, irrespective of which criterion is used, these
procedures do not acknowledge the nested nature of
data, thereby leading to simplistic ranking of services in
which patient casemix is not taken into account.
Accordingly, we sought to build on the reported
findings by accessing IAPT data collected as part of the
second round of the National Audit of Psychological
Therapies [17] in order to test one primary proposition,
namely that the variability between service providers
would have a significant effect on patient outcomes
while the therapy they received, counselling or CBT,
would not. Such a finding would support the argument
that the focus of research attention has been misplaced
by investing in the apparent superiority of one model of
psychological intervention over another rather than
investing in the study of the variability in patient
outcomes between different psychological therapy sites
or providers. A secondary aim was to consider any
differences in the effectiveness of the two therapies in
relation to the number of sessions that patients attend.
Methods
Study sample
Access to data from IAPT services participating in the
second National Audit of Psychological Therapies
(NAPT) was granted from the Healthcare Quality Im-
provement Partnership (HQIP). The aim of the audit
was to evaluate the quality of treatment and care re-
ceived by people seeking psychological therapy services
for common mental health disorders in England and
Wales as a basis for service improvement. Reflecting the
focus on services and service outcomes, data was not
collected on therapists and therapists were not recog-
nised or identifiable in the data. The baseline audit was
carried out in 2010 and published in November 2011
[23] with a second round of the audit conducted 18 to
24 months after the baseline to determine whether
performance had improved [17]. The current study used
only IAPT data from the second audit of all NHS-
funded psychological therapy services for adults in
primary and secondary care in England and Wales. Data
were requested on all patients discharged from services
between 1st July and 31st October 2012.
The full NAPT retrospective case record comprised
data from 122,812 individual patients from both IAPT
and non-IAPT sites. IAPT services (N = 121) provided
117,750 case records. In order to determine a change
score as well as excluding patients who only received an
initial assessment (i.e., one session), patients were
excluded if they did not receive two or more sessions of
a step 3 therapy for depression (CBT or counselling), or
had missing data for important variables; pre or post-
therapy outcome measures, ethnicity (used as a proxy
measure of socio-economic deprivation) and the reason
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for treatment ending. Further, because we were inter-
ested in both the variability between services, the ‘site ef-
fect’, and the reliability of model coefficients, services
that provided data on fewest patients were excluded
while maintaining the recommended number of services
to reliably estimate site effects [24, 25]. These exclusions
resulted in a study sample of 33,243 patients (CBT:
n = 23,595; counselling: n = 9648) treated at 103
sites (Fig. 1). The number of patients per site ranged
from 21 to 1858. Patients were allocated to treatment
through standard routine practice procedures. Such de-
cision rules vary across services but will include avail-
ability of a practitioner regardless of their theoretical
orientation, assignment by a step 2 practitioner in terms
of the issues identified by the patient (e.g., relationship
issues being assigned to counselling and specific prob-
lems being assigned to CBT), or patient stated prefer-
ences. However, there are no national guidelines as to
which therapy a patient should be referred to other than
the previously stated CBT as the frontline treatment and
counselling as a second line treatment.
Sample characteristics
The patient demographic profile of the study dataset
was comparable to that of all patients accessing any step
3 psychological intervention within the full NAPT
dataset [17] with 66% female, 83.7% white British and a
mean age of 40.99 (SD 13.86) years. A primary present-
ing problem was recorded for 21,105 (63.5%) patients,
with the largest categories being depressive episode
(15.8%), anxiety and depression (15.7%), and Generalised
Anxiety Disorder (7.1%). Other problems included
recurrent depressive episode (5%), panic disorder (3.1%),
post traumatic stress disorder (PTSD) (3.1%), and
Obsessive Compulsive Disorder (OCD) (3%). The pro-
portion of patients that completed therapy was similar
in both treatments: 68.2% for CBT and 69.4% for coun-
selling (χ2 (1) = 4.512 p = 0.034).
Therapists
Therapist level data were not available in the NAPT
dataset. However, all practitioners delivering CBT or
generic counselling within IAPT are typically trained to
post-graduate diploma level and receive regular supervi-
sion as set out within IAPT guidance.
Psychological interventions
In terms of defining these two forms of psychological
therapy, CBT is based on the premise that the way we
feel is affected by our thoughts, beliefs and by how we
behave. People become depressed for many different
reasons, for example due to stress or relationship break-
down. Depression tends to trigger negative thoughts,
which can increase depression and lead to negative
behaviour. Changing how a person thinks when de-
pressed, and what they do as a result, can also change how
they feel. CBT involves planning practical exercises or ex-
periments, encouraging people to engage in activities and
to write down their thoughts and problems for discussion
during therapy. CBT can also involve problem-solving and
learning how to deal with worry or with difficult memor-
ies [26].
With regards to generic counselling, it is more difficult
to define as there are many different theoretical ap-
proaches that a counsellor could be trained in, meaning
they may work with patients in different ways. Although
the National Audit of Psychological Therapies did not
require practitioners to provide any details about the
form of counselling they delivered, ‘counselling’ was an
option alongside specific modalities including CBT,
Interpersonal Therapy, Solution Focused Therapy, and
Cognitive Analytic Therapy. Therefore it can be assumed
that practitioners who selected ‘counselling’ were provid-
ing something different to those specific modalities.
Many counsellors practise in an integrative manner
where they bring skills and knowledge from training
underpinning different forms of therapy. Typically,
counselling involves a series of formal sessions, usually
six to twelve sessions, where the therapist and the client
talk about the client’s issues and feelings. Therapy may
involve talking about life events, feelings, emotions,
relationships, and ways of thinking and patterns of
behaviour. The therapist will listen, encourage and em-
pathise, but will also challenge in order to help the client
see their issues more clearly or in a different way. Coun-
selling is not about giving advice or opinions, nor is it a
friendly chat with a friend. The therapist helps the client
to understand themselves better and find their own
solutions to resolve or cope with their situation [27].
Outcome measures
Because of the high level of comorbidity between depres-
sion and anxiety, the IAPT programme uses two primary
outcome measures: the Patient Health Questionnaire-9
(PHQ-9) [28] and the Generalised Anxiety Disorder-7
(GAD-7) [29].
The Patient Health Questionnaire-9 (PHQ-9) [28] is a
brief 9-item self-report measure of depression derived
from the Patient Health Questionnaire and constitutes a
self-administered version of the PRIME-MD. It is a
measure designed to assist medical practitioners making
criteria-informed diagnoses of DSM-IV disorders com-
monly experienced by medical patients. The measure
uses a 4-point Likert-type scale with scores ranging from
0 (“not at all”) to 3 (“Nearly every day”) with total PHQ-
9 scores ranging from 0 to 27. The time frame captured
by the PHQ-9 comprises a two-week time period prior
to completing the questionnaire. Scores of 10 and above
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on the PHQ-9 are demarcated as clinical scores and
these scores showed criterion validity when assessed
against mental health professional interviews [28]. Severity
bands (and range of scores) are as follows: minimal/mild
(0–9), moderate (10–14), moderately severe (15–19), and
severe (20–27). Tested on a sample of 3000 primary care
patients and 3000 obstetrics/gynaecology patients in the
United States, the PHQ-9 has an internal reliability of 0.89
and a test-retest reliability of 0.84 across 48 h [28].
The GAD-7 is a 7-item self-report scale used to
identify and measure the severity of generalised anxiety
disorder. Scores range from 0 to 21, with a cut-off score
of 8 or above distinguishing between clinical and non-
clinical populations. Severity bands (and range of scores)
are as follows: minimal/mild (0–9), moderate (10–14),
and severe (15–21). Tested on a sample of 2739 primary
care patients in the United States, the GAD-7 has an
internal reliability of 0.92 and a test-retest reliability of
0.83 [29].
Statistical analysis
Data were analysed using SPSS v 22 and MLwiN [30, 31].
Comparisons were made between CBT and counselling
patients in terms of their intake severity levels of PHQ-9
and GAD-7 and their outcomes, pre-post change on
PHQ-9 and recovery. The number of sessions attended by
patients was also compared. Following this descriptive
analysis, multilevel modelling (MLM) was utilised to
model predictors of pre-post change.
Criteria for determining recovery, improvement, no
change, and deterioration
Analysis considered levels of clinical improvement and
deterioration experienced by patients in the dataset
Fig. 1 Flowchart
Pybis et al. BMC Psychiatry  (2017) 17:215 Page 5 of 13
using criteria of reliable and clinically significant change
[21, 22]. Reliable and clinically significant improvement
(RCSI) and associated change criteria are common indi-
ces of change in psychological therapy studies. Following
the procedures set out by Jacobson and Truax [22], we
considered patients had achieved RCSI if they (a)
entered treatment in a dysfunctional state and left
treatment in a normal state, and (b) having changed to a
degree that was probably not due to measurement error,
that is, by an amount equal to or greater than the
reliable change index (RCI) described below.
We found an RCI for the PHQ-9 of 5.9 points, compar-
able to 6 points used by other researchers [22, 32]. There-
fore, we also used an RCI of 6 or more point
improvement to indicate reliable improvement and 6 or
more point deterioration to indicate reliable deterioration.
Clinical improvement can only be applied to patients
above the clinical cut-off at intake – that is a score of 10
or more. Reliable change could therefore be applied to the
full dataset, while reliable and clinically significant change
could only be applied to patients clinical at intake.
Multilevel modelling
Using iterative generalised least squares (IGLS) methods,
a regression model was developed to identify significant
patient variables, before including therapy type, the
number of sessions attended and site effect. Continuous
variables were added ‘grand mean centred’ to aid inter-
pretation [24]. Therapy type, along with other patient
variables, was deemed a statistically significant predictor
of change if its coefficient was more than 1.96 times the
standard error [31]. The significance of the improvement
in the model fit, in the development from a single level
model to a multilevel model, was considered by testing
the difference in the −2*loglikelihood ratio produced by
each model, against the chi squared distribution for the
degrees of freedom of the additional parameters [31].
Using the estimates produced by the IGLS model as
‘priors’, Markov chain Monte Carlo (MCMC) procedures
were applied. The size of the site effect was estimated as
the percentage of the total variance that was at the site
level and 95% Probability Interval (PrI) for this estimate
was derived from the 2.5 percentile and 97.5 percentile
values of the MCMC simulations chain [33].
Results
First we present descriptive statistics regarding pre-
therapy severity, the extent of change including rates of
reliable and clinically significant change following psycho-
logical interventions and the number of sessions attended.
We then focus on presenting an account of and results
from the multilevel model development to consider po-
tential predictors of outcome, including therapy type, and
to estimate the size and significance of site effects.
Descriptive statistics: Intake severity, pre- and post-therapy
status and change
Table 1 presents the severity levels on the PHQ-9 for
patients accessing CBT and counselling. Fewer mild and
severe patients and more moderate and moderate-to-
severe patients accessed counselling compared to CBT.
With regard to the GAD-7, fewer severe patients
(scoring 15–21) and more patients scoring 0–9 or 10–14
accessed counselling than CBT.
For depression, the pre-therapy PHQ-9 mean (SD) for
CBT was 15.4 (6.52) while for counselling it was also
15.4 (6.34). The mean (SD) pre-post change on PHQ-9
was 6.1 (6.96) for CBT and 5.9 (6.78) for counselling
(t = 1.61 (18,361.8), p = 0.11). The post-therapy means
(SD) were 9.3 (7.25) and 9.4 (6.98) respectively, yielding
pre-post effect sizes (95% CI) of 0.94 (0.92, 0.95) for
CBT and 0.95 (0.92, 0.98) for counselling.
The analysis was repeated for patients who scored
above the clinical cut-off on PHQ-9 at intake. Here
the pre-therapy PHQ-9 means (SD) for CBT and
counselling were 17.9 (4.57) and 17.7 (4.56) respectively.
The mean (SD) pre-post change was 7.3 (6.95) for CBT
and 7.1 (6.71) for counselling (t(14,908.7) = 1.70,
p = 0.09), giving post-therapy means (SD) of 10.6 (7.28)
and 10.6 (7.02) and yielding pre-post effect sizes (95% CI)
of 1.59 (1.58, 1.62) for CBT and 1.55 (1.52, 1.59) for
counselling.
Reliable and clinically significant improvement
For all patients attending services (i.e., clinical and non-
clinical at intake), irrespective of the therapy received,
50.1% reached the criterion for reliable improvement on
the PHQ-9, while 3.5% reliably deteriorated. The scores
for the remaining 46.4% of patients did not reliably
change. For CBT, 50.4% of patients made reliable
improvement, 3.6% reliably deteriorated and 46.1% did
not reliably change. The corresponding figures for
counselling were 49.6%, 3.3% and 47.1%. Considering
only patients scoring above the clinical cut-off at intake
(N = 26,527), a total of 46.6% of patients receiving CBT
and 44.3% of patients receiving counselling achieved
reliable and clinically significant improvement on the
PHQ-9.
Table 1 Pre-therapy PHQ-9 scores and severity bands
PHQ-9 score and severity band CBT % (N) Counselling % (N)
0–9: Minimal/Mild 20.5 (5670) 19.8 (2265)
10–14: Moderate 21.7 (5994) 22.1 (2529)
15–19: Moderate-to-severe 27.0 (7467) 28.9 (3311)
20–27: Severe 30.9 (8550) 29.2 (3335)
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Sessions attended
Overall, the mean (SD) number of sessions attended was
8.5 (6.18), with a median (IQR) of 7 (4–12) sessions. For
CBT, the mean (SD) was 8.9 (6.34) sessions, with a me-
dian (IQR) of 7 (4–12) sessions, while for counselling
the figures were, 7.5 (5.54) sessions and 6 (3–10) ses-
sions (Mann Whitney U, p < 0.001). Figure 2 presents
the differences between the two therapies in terms of
the number of treatment sessions patients had attended
by the end of therapy and shows that patients receiving
counselling generally had fewer sessions. For example,
74.4% of counselling patients had nine sessions or less
compared with 62.3% of CBT patients.
Multilevel model development
For the outcome ‘pre-post change in PHQ-9 scores’, a
single level regression model identified patient intake
severity on both PHQ-9 and GAD-7 and ‘Ethnicity’ as
significant predictors of outcome. Adding therapy type,
with CBT as the reference category, found that counsel-
ling reduced the amount of change on PHQ-9 by 0.195
(S.E. 0.080) of a point. However, this small but statisti-
cally significant amount was reduced and was no longer
significant when ‘sessions attended’ was added to the
model, although an interaction between number of ses-
sions and therapy type was statistically significant. Intake
PHQ-9 and sessions attended had non-linear relation-
ships to pre-post change and both were included in the
model as polynomial terms. Extending this model to a
multilevel model significantly reduced the −2*loglikeli-
hood ratio (χ2(1) = 326.28, p < 0.001), indicating a sig-
nificant improvement in model fit. Significant random
slopes were found for intake PHQ-9 (χ2(2) = 113.37,
p < 0.001), and sessions attended, (χ2(3) = 34.68,
p < 0.001), indicating that the effect that intake PHQ-9
score and sessions attended had on patient outcomes
varied between sites.
The full model derived using IGLS was developed
using MCMC procedures. MCMC found that 20,000
iterations were sufficient for convergence of all
estimates, and the testing of model assumptions using q-
q plots and consideration of homoscedasticity indicated
that normality can be assumed.
The MCMC model
The final MCMC model (see Additional file 1) contained
patient variables, therapy type and sessions attended,
and the significant interactions between them. The
model shows that three variables, PHQ-9 score at intake,
the number of sessions attended, and the interaction
between them, had positive coefficients (SE), of +0.485
(0.010), +0.287 (0.009) and +0.019 (0.001) respectively.
With regard to PHQ-9 score, for each point above aver-
age on PHQ-9 at intake (15.4), change increased by just
under half a point, while for each point below average at
intake change reduced by the same amount. However,
this is likely to be a statistical function due to higher in-
take scores having greater scope to change. Attending
more sessions than average generally increased the
amount of change by about a quarter of a point for each
additional session, while patients who had above average
intake scores and also attended above average number of
sessions had a further small increase in change com-
pared to patients who were above average on only one
or neither of the variables.
Although, the modelling of the curvilinear relationship
between intake score and change and also between
sessions attended and change improved the model fit,
the curves were slight and the coefficients for the
squared terms small at −0.003 and −0.01 respectively.
Fig. 2 The number of sessions attended by CBT and counselling patients (N = 33,243)
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The effects though small indicate that for both variables,
as values increase from the average to the maximum, the
positive effect of increases is reduced and the reduction
is greatest at the largest values. Conversely, the negative
effect on change of below average intake scores and
sessions attended is reduced as they decrease.
Higher than average GAD-7 scores at intake reduced
change while lower scores increased change. The coeffi-
cient (SE) of −0.108 (0.009) indicates that for a max-
imum score on GAD-7 of 21, change on PHQ-9 would
be reduced by about 0.7 of a point, while a GAD-7 score
of zero would increase change by about 1.5 points. The
coefficient (SE) for the interaction between PHQ-9 in-
take score and GAD-7 intake score, −0.01 (0.001), shows
that higher than average intake scores on both PHQ-9
and GAD-7 reduced change on PHQ-9 compared to pa-
tients who were not above average on both, although the
effect was small. Patient ethnicity was also a significant
predictor, with ‘non-white British’ patients having about
half a point less change, coefficient (SE) -0.536 (0.100),
compared to ‘white British’ patients.
Therapy type
The model found that therapy type was not a significant
predictor of change on PHQ-9 with a coefficient (SE) for
counselling of −0.073 (0.081) and a 95% PrI of −0.232 to
+0.085. However, the small but statistically significant
coefficient for the interaction between therapy type and
sessions attended indicated that where patients receiving
counselling had more than the average number of ses-
sions, they tended to show less improvement than CBT
patients with same numbers of sessions. For each session
above average, counselling patients showed 0.066 of a
point less change compared to CBT, but more change by
the same amount per session where patients had less
than the average number of sessions.
Site effect
The model shows that although the amount of patient
pre-post change on PHQ-9 for the average site was
6.729 points, it varied between sites, with a variance (SE)
of 0.677 (0.123). The variance of residuals at the patient
level was 35.716, therefore, the proportion of the total
variance at the site level was 1.8%. MCMC indicated that
this significant site effect had a 95% PrI of 1.3% - 2.6%.
The random slopes found for intake PHQ-9 score and
sessions attended indicate that the effect that both
variables have on outcome varied between sites. The var-
iances (SEs) were small, 0.004 (0.001) and 0.003 (0.001)
respectively, but the positive covariance (SE) between
the intercept variance and the slope variance for PHQ-9
score, of 0.051 (0.010), describes a ‘fanning-out’ of the
regression lines for sites. This indicates that as patient
intake severity increased, there was greater variability
between sites. Although the covariance (SE) between
intercept variance and slope variance for sessions attended
was also positive 0.010 (0.008), the ‘fanning-out’, that is the
increase in variability between sites as number of sessions
increased, was not significant.
In Fig. 3, the variability between sites is described by
ranking and plotting the 103 site residuals, derived from
the model, with their 95% confidence intervals (CIs). As
the model indicated, the average pre-post change for
sites was 6.729 points but the site residuals show that
the additional impact of each site varied from around
−1.5 to +2.0 points. However, where the 95% CI for a
site residual crosses zero, represented by the horizontal
dashed line, the impact that the site has on outcomes is
not significantly different to that of the average site.
Accordingly, 72 (69.9%) sites, in grey, were not deemed
to be significantly different to average, while 16 sites
(15.5%) located to the left of the plot in red, were less ef-
fective than average and 15 (14.6%) sites on the right, in
green, were more effective than average.
That the 95% confidence intervals of the ‘less effective
than average’ and ‘more effective than average’ sites do
not overlap would indicate that their impacts on change
are significantly different. This is supported by compari-
sons between the three groups of sites in terms of their
pre-post change on PHQ-9 in the full sample and recov-
ery rates in the clinical sample. For the less effective
sites, the mean pre-post change (SD) was 5.0 (0.68)
points and the recovery rate (Range) was 42.7% (32.0% -
48.0%), while for more effective sites, the mean pre-post
change (SD) was 7.0 (1.06) points and the recovery rate
(Range) was 58.7% (51.4% - 66.3%). The mean pre-post
change (SD) for average sites was 6.0 (1.09) while the re-
covery rate was 51.0% with a wide range (19.4% - 72.2%)
that included the sites with the lowest and highest
recovery rates overall. These two sites can be seen in
Fig. 3 as the lowest and highest ranked average (grey)
sites, classified as average by the multilevel model due to
Fig. 3 Caterpillar plot of the ranked residuals of 103 services with
their 95% Confidence Intervals (CIs)
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case-mix adjustments and the wide 95% confidence in-
tervals for their estimated residuals.
Therapy type, recovery and sessions
As the model indicated, where patients had more than the
mean number of sessions (8.5), CBT was slightly more ef-
fective. In order to consider further the relationships be-
tween therapy type, sessions attended and outcomes, Fig.
4, compares recovery rates for CBT and counselling for
patients who received 2–20 sessions, and also shows the
numbers of patients included in the calculation of rates.
In total, 94.8% of patients who scored in the clinical range
at intake had between 2 and 20 sessions.
Figure 4 shows that for 2 to 7 sessions (representing
54% of patients), counselling had higher recovery rates
while for 8 or more sessions CBT had higher rates and
the difference in rates appears to widen as the number
of sessions increases. However, as the number of ses-
sions increases, the recovery rates were based on fewer
patients, particularly for counselling. Consideration of
95% CIs around these recovery rates indicated that only
where patients had either 18 or 20 sessions was CBT sig-
nificantly more effective, with recovery rates (95% CIs)
of 62.2% (57.1, 66.9) and 62.4% (56.5, 68.0) respectively,
compared with 44.4% (32.7, 56.6) and 42.6% (30.0, 55.9)
for counselling. The confidence intervals of the recovery
rates overlapped for all other sessions, apart from where
patients attended only two sessions. Where patients
attended two sessions, counselling was significantly
more effective, with a recovery rate (95% CI) of 34.9%
(31.9, 37.9) compared with 22.2% (20.5, 24.0) for CBT.
Discussion
Comparative effectiveness of CBT and counselling
The current study utilised a large dataset comprising in
excess of 30,000 patients seen at over 100 sites and col-
lected as part of a national audit of psychological therap-
ies and found the outcomes of CBT and generic
Fig. 4 Number of sessions attended (2–20) and recovery rates (Clinical sample: N = 26,527)
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counselling to be comparable and that the model of
therapy did not predict outcome. By contrast, there was
significant variability between sites, with approximately
15% of sites yielding reliably more effective patient
outcomes and a similar percentage yielding reliably less
effective outcomes. The mean recovery rates for these
two groupings were 59% and 43% respectively and the
most effective site had a recovery rate more than twice
that of the least effective site. Importantly, in the current
study we employed multilevel modelling to capture the
nested nature of routinely collected service level data and
also controlled for patient variables and sessions attended.
Hence, if the less effective sites were treating more severe
patients, this was accounted for in the analysis.
Accordingly, our findings strongly suggest that, despite
the very different recommendations for CBT and coun-
selling in the NICE Guidelines for Depression in Adults
[3], it would appear that the two therapies have a very
similar impact in routine practice for the treatment of
depression. Indeed, as observed in the current data, CBT
only had significantly better outcomes than counselling
for patients attending 18 and 20 sessions, which only
accounted for 3.2% of the patients who attended up to
the 20 sessions. By contrast, for 12.9% of patients who
attended two sessions, counselling was significantly
more effective. However, for the vast majority of patients
(i.e., 83.9%) there were no significant differences in out-
comes between the two therapies and hence no rationale
for suggesting CBT to be superior to generic counselling
in the treatment of depression.
Our results contrast with findings from previous
research that structured and focused interventions such
as CBT are more efficacious than unstructured non-
specific interventions, of which counselling is often cate-
gorised [6]. Furthermore, it has been reported that when
psychological therapy is efficacious, post-treatment effect
sizes are higher for high-severity patients than for low-
severity patients [34]. It could be inferred that non-
specific therapies (i.e., counselling) may be less efficacious
for high-severity patients than a specific therapy (i.e.,
CBT). Our findings do not support this hypothesis. In line
with the findings reported here, when counselling as deliv-
ered within the UK primary healthcare setting of IAPT
services has been directly compared to more structured
psychological interventions such as CBT, the two inter-
ventions have been consistently reported to be compar-
able [8, 10]. To further test this proposition, a large scale
randomised controlled trial comparing the efficacy and
cost-effectiveness of Counselling for Depression with CBT
as delivered within an IAPT service is currently underway
[35]. Using a non-inferiority analysis this trial will enable a
comparison of a specific manualised form of counselling
to be compared to CBT in a sample of patients presenting
with moderate or severe depression.
The findings reported here extend and refine previous
evaluations from IAPT data that suggested counselling
and CBT are equally effective in the treatment of depres-
sion [15, 19, 20]. Similar findings of broadly equivalent
outcomes for depression have been reported from the
analyses of other large UK routine practice datasets that
pre-dated the IAPT initiative [6, 11]. Taking a perspective
that considers the weight of evidence rather than just
RCT methodology, there seems little evidence for NICE
guidance to continue to suggest or label counselling as a
second line intervention for the treatment of adult
depression.
Variability between sites
Although it is clear the type of therapy provided to
patients with depression has little differential impact on
outcomes, there are other factors that may have a
greater role in whether or not a patient responds well to
psychological therapy. The results presented here de-
scribe the variability between sites in terms of outcomes
for patients, with some sites yielding significantly better
outcomes than others after controlling for patient vari-
ables, therapy type and sessions attended. This finding is
consistent with other accounts showing large variability
in outcomes across IAPT sites [16]. Our results suggest
that if the 16 less effective sites had outcomes similar to
average sites, then a further 364 patients would have
recovered across those sites in in a 4-month time period.
Previous research has also identified variability in
another key service variable – therapists – as an import-
ant factor for patient outcomes [36, 37]. A recent study
of a single IAPT service, included but not identifiable in
the NAPT audit, yielded a therapist effect of 5.8% [38].
While the data available in the present study did not
allow exploration of therapist effects, the growing evi-
dence for variability of sites and therapists suggests a
need for a move away from debates about the superiority
of one brand of therapy over another and towards a
more comprehensive understanding of the factors that
contribute to some services – and therapists – yielding
more effective patient outcomes than others and, more
importantly, understanding why some sites are yielding
less effective patient outcomes. Socio-economic status
and intake severity have been reported to impact on out-
comes [39–41]. It is possible that some services have a
higher proportion of complex cases or of unmeasured
patient factors in their populations that would account
for poorer overall outcomes.
Efficiency
Although overall there was no difference in outcomes
between the two therapies, and a significant difference at
only 2, 18 and 20 sessions, our findings suggest that
CBT tends to be more effective at 8 or more sessions
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while counselling tends to be more effective at less than
8 sessions. Given that the majority of patients in IAPT
are being treated in fewer than ten sessions, this finding
is of some significance and warrants further investigation
as it could be argued that counselling is more efficient
than CBT in treating depression. Such a finding could
have positive cost implications for the NHS.
Caveats
There are a number of caveats to this study. First,
although the study did not sample all IAPT services, an
approximate 50% data capture of all services suggests a
broadly representative sampling frame. In addition, the
ratio of patient numbers for CBT and counselling in the
sample (2.2:1) is similar to that reported in the 2013/14
HSCIC report (2.4:1) [15]. Second, a standard criticism
of data captured by these methods being used to make
treatment comparisons is that there is no randomisation
of patients and no independent fidelity checks that the
therapies as labelled would meet respective quality
checks. While the feasibility of such independent checks
is doubtful in routine practice, there are standards of
supervision for the delivery of therapies in IAPT that are
assumed to have been adhered to by all services. In
addition, there is no reason to believe there is any effect
that would systematically favour or weaken one of the
interventions over the other. However, a randomised
non-inferiority trial would be required to provide a more
definitive answer to the question posed here.
Third, the data comprises only pre- and post-therapy
data and so the number of sessions required to meet
clinical change was calculated based on the point at dis-
charge. Not available in the dataset was the weekly
PHQ-9 score recorded at each session. Analyses of this
data might have yielded evidence showing that patients
met the required threshold in fewer sessions than
reported in this study. However, given the sessional data
is mandated by the IAPT services and was available to
the clinicians, there is no reason to suppose that the
point of discharge would have been any different than
that reported in this study. Finally, while the NAPT data
captured service-level data, it did not collect therapist
level data. Nesting patients within therapists, who are
nested within sites in a three level model would have
allowed the estimation of both therapist effects and site
effects and the contribution both make to patient
outcomes. There is a need for further studies of large
datasets that contain and identify the three levels.
Conclusions
It is apparent from the findings presented here that
counselling is not inferior to CBT and there would seem
little, if any, rationale for committing public money to
fund superiority trials of CBT in the field of depression.
Instead, attention needs to be focused on factors other
than therapy type that may influence outcomes, namely
the factors associated with the variability between ser-
vices including therapists. Such attention should adopt
multilevel modelling as the analytic approach in order to
capture the naturally nested nature of the delivery of
psychological therapies [42]. However, future research
aims to explore the efficacy of non-CBT psychological
therapies using a randomised controlled trial design,
adopting CBT as the comparator condition in order to
build the evidence base for alternate bona fide therapies
and enable greater provision and choice for patients.
There is also a need to undertake more thorough
analyses of existing datasets, particularly the routine data
collected by IAPT to take account of the issues raised in
this paper. Finally, in the context of the very small
differences between psychological interventions, what is
striking from the results in the current audit is that the
scores of approximately half of all patients, regardless of
the intervention received, either did not achieve reliable
improvement or reliably deteriorated. It is a salutatory
reminder of the extent of work remaining to be done re-
garding the implementation and delivery of effective psy-
chological therapies and where efforts might better be
focused rather than on pursing research into insignifi-
cant differences between the effectiveness of differing
models of psychological interventions.
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